Neuroendocrine cells (AR/PSA negative) are often present in small number within luminal prostate tumors, and their ability to grow without androgen stimulation cause them to be enriched within the tumor after ADT therapy cycles (17, 18). This evidence concerns the gene KLK3 and neoplasm.